China is rapidly constructing extensive domestic biobanks, aiming to establish a research capacity comparable to that of the United States. This initiative is partly driven by increasing geopolitical tensions and restricted access to Western biomedical databases. Experts note the growing recognition of biodata as a strategic resource in the US, highlighting the global competition in biotechnology and the bioeconomy. AI
IMPACT Potential for accelerated drug discovery and development in China, impacting global pharmaceutical R&D.
RANK_REASON Significant geopolitical competition in a key technological area (biotechnology) between major global powers.
Read on CSET (Georgetown — Center for Security & Emerging Tech) →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
